28730-78-1

Basic information

• Product Name: Dimethyl 4-bromoisophthalate
• Synonyms: Dimethyl 4-bromoisophthalate
• CAS NO: 28730-78-1
• Molecular Formula: C₁₀H₉BrO₄
• Molecular Weight: 273.09
• Mol File: 28730-78-1.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 331.7±22.0 °C(Predicted)
• Appearance: /
• Density: 1.505±0.06 g/cm3(Predicted)
• CAS DataBase Reference: Dimethyl 4-bromoisophthalate(CAS DataBase Reference)
• NIST Chemistry Reference: Dimethyl 4-bromoisophthalate(28730-78-1)
• EPA Substance Registry System: Dimethyl 4-bromoisophthalate(28730-78-1)

Safety Data

• Hazardous Substances Data: 28730-78-1(Hazardous Substances Data)

Usage

General Description

Dimethyl 4-bromoisophthalate is a chemical compound with the molecular formula C10H9BrO4. It is a white to off-white crystalline powder that is primarily used as a reagent in organic synthesis and polymerization reactions. Dimethyl 4-bromoisophthalate is a derivative of isophthalic acid, with the presence of a bromine atom at the 4-position. Dimethyl 4-bromoisophthalate is commonly employed in the preparation of block copolymers and as a mediator in controlled radical polymerization. It acts as a source of bromine atoms for initiating polymerization reactions and is often used in conjunction with other monomers to produce specialty polymers with well-defined properties and structures. Additionally, this compound is utilized in the manufacture of specialty chemicals and pharmaceuticals. Overall, Dimethyl 4-bromoisophthalate has diverse applications in the field of organic chemistry and material science.

Upstream product

• 6939-93-1 4-bromo-isophthalic acid 
• 74-88-4 methyl iodide 
• 67-56-1 methanol 

Downstream Products

• 58761-96-9 4-[4'-methylthio-2'-(n-hexyl)-phenoxy]-isophthalic acid 
• 148291-61-6 3-carbomethoxy-4-(methoxyphenoxy)benzoic acid methyl ester 
• 53063-31-3 4-phenoxy-1,3-benzenedicarboxylic acid dimethyl ester 
• 412031-32-4 dimethyl 4-cyano-1,3-benzenedicarboxylate 
• 50970-94-0 4-(3-methoxyphenoxy)-1,3-benzenedicarboxylic acid 
• 1262893-98-0 (S)-6-methoxy-9-oxo-N-(1-(p-tolyl)ethyl)-9H-xanthene-2-carboxamide 
• 1577288-87-9 1,3-bis(hydroxymethyl)-4-[3-[(tert-butoxycarbonyl)amino]propyl]benzene 
• 1577288-88-0 1,3-bis(aminomethyl)-4-[2-[(tert-butoxycarbonyl)amino]ethyl]benzene 
• 1577288-89-1 1,3-bis(aminomethyl)-4-[3-[(tert-butoxycarbonyl)amino]propyl]benzene 
• 1577289-08-7 C₁₅H₂₁N₇O₂ 
• 1577289-09-8 C₁₆H₂₃N₇O₂ 
• 1577288-86-8 1,3-bis(hydroxymethyl)-4-[2-[(tert-butoxycarbonyl)amino]ethyl]benzene 
• 1577289-07-6 C₁₈H₂₅NO₆ 
• 58762-16-6 methyl 7-(S-methylsulfonimidoyl)-5-(n-hexyl)-xanthone-2-carboxylate 

Relevant articles and documents

High Water Adsorption MOFs with Optimized Pore-Nanospaces for Autonomous Indoor Humidity Control and Pollutants Removal

The indoor air quality is of prime importance for human daily life and health, for which the adsorbents like zeolites and silica-gels are widely used for air dehumidification and harmful gases capture. Herein, we develop a pore-nanospace post-engineering

TERTIARY ALCOHOL IMIDAZOPYRAZINE BTK INHIBITORS

Provided are Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula (I), pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, or their use in therapy.

SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF

This invention provides compounds of formula (I): wherein R1a, R1b, Ra, R2a, R2b, R1, and X have values as described in the specification, useful as inhibitors of HDAC6. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of proliferative, inflammatory, infectious, neurological or cardiovascular diseases or disorders.